Alnapharm

Patient

Everyone should be aware of his true nature. We want to do our part, that you feel more comfortable as a human being and less than a patient.

At every stage of drug development is about getting to reduce the side effects of each medication and to optimize the efficiency.

The safety and efficacy of new drugs is being tested in comprehensive preclinical and clinical studies.

Despite very large study groups extremely rare side effects cannot always be determined.

Alnapharms responsibility for the patient, therefore also extends to the continuous security monitoring of his medication.

Products

The first healthcare product of Alnapharm is the dietary supplement OSVALIN®. OSVALIN® is a unique silicon preparation containing hydrolyzed, colloidal silicon dioxide in the highest possible concentration.

more >>

Responsibility

We want to take responsibility for each project that we are launching and with the specific task that goes with it. We are aware of the importance of our projects, with which we enter into an obligation to use our work for the highest good of the patient.

more >>

Research and Development

As man is a complex creature itself, we derive our knowledge of the complexity of the plants, the active ingredients that nature gives us. We strive to receive our developments from what already exists.

more >>

Newsroom

Stay informed about our newest inovations and achievments

more >>